MERZ-AESTHETICS
Merz Aesthetics is presenting at the 2023 International Master Course on Aging Science (IMCAS) World Congress a total of 10 abstracts highlighting its medical aesthetics product portfolio and addressing the evolving needs of a diversifying society and rapidly changing patient demographics. This year’s IMCAS is a hybrid event, allowing participants to attend live in Paris or virtually beginning Thursday, January 26 to Saturday, January 28.
“Merz Aesthetics takes a long-term and responsible look at how patients are treated – especially as individuals from a widening spectrum of age groups and socioeconomic and ethnic backgrounds seek medical aesthetic treatments,” said Terri Phillips, M.D., chief medical affairs officer, Merz Aesthetics. “We are proud to contribute data that provide new insight into individualized treatment approaches that improve outcomes for unique patient needs and strengthen the safety and efficacy profile of our portfolio.”
“Our focus in this year’s Merz Aesthetics Symposium at IMCAS Congress is the management of skin quality as a priority within the overall aesthetic treatment journey”, said Frank Brandt-Pollmann, President EMEA, Merz Aesthetics. “We aim to empower medical aesthetics experts with latest trends in an evidence-based way.”
Merz Aesthetics organized a program led by notable medical aesthetic experts, participating in various IMCAS sessions and presenting new data throughout the event.
- Merz Aesthetics Symposium Mastering Skin Quality and Rejuvenation: A Mindset Shift Led by Science – Dr. Niamh Corduff, Dr. Sonja Sattler, Dr. Luiz Perez, Dr. Omar Haroon, Friday, January 27, 2023, 10:30 a.m. – 12:30 p.m. CEST
- Merz Aesthetics Support of IMCAS Cadaver Workshop – Anatomist Prof. Dr. Thilo Schenck and Aesthetic Specialist Dr. Welf Prager, Thursday, January 26, 2023, 4:00 p.m. – 4:30 p.m. CEST
- Product Analysis Session “Emerging Toxins” – PH.D. Andy Curry, associate medical director, Merz Aesthetics, Friday, January 27, 2023, 8:30 a.m. ‒ 10:00 a.m. CEST
- IMCAS Economic Tribune Roundtable – Bob Rhatigan, CEO Merz Aesthetics, Friday, January 27, 2023, 2:00 p.m. – 3:30 p.m. CEST
- IMCAS Product Analysis Session “Tear Trough Fillers” – Dr. Sonia Sattler, Dermatologist , Saturday, January 28, 2023, 8:30 a.m. – 10:00 a.m. CEST
Oral Presentations
- Global Facial Rejuvenation Results in Sustained Long-Term Patient Satisfaction. Presenting author: Dr. Kachiu Lee, Friday January 27, 2023, 11:40 a.m. CEST, Session: Contributing Lectures ‒ Injectables
E-Poster Presentations
Virtual posters will be available for viewing on-site throughout the congress and displayed on the virtual e-poster platform with detailed abstracts.
- Skin Quality – A Holistic 360° View: Consensus Results. Presenting author: Dr. Kate Goldie. Co-authors: Dr. Martina Kerscher, Dr. Sabrina Guillen Fabi, Dr. Cyro Hirano, Dr. Marina Landau, Dr. Tingsong Lim, Dr. Heather Woolery-Lloyd, Dr. Kavita Mariwalla, Dr. Je-Young Park, Dr. Yana Yutskovskaya
- HSA as a Stabilizer on Aesthetic Injectables. Presenting author: PH.D. Andy Curry; Co-authors: Dr. Sonja Sattler, Dr. Stephen Gollomp
- Consensus on the Use of Hyaluronic Acid Fillers from the Cohesively Densified Matrix Range: Best Practice in Specific Facial Indications. Presenting author: Dr. Jani van Loghem. Co-authors: Dr. Sonja Sattler, Dr. Gabriela Casabona, Dr. Sebastian Cotofana, Dr. Sabrina Guillen Fabi, Dr. Kate Goldie, Dr. Uliana Gout, Dr. Martina Kerscher, Dr. Tingsong Lim, Dr. Carla de Sanctis Pecora, Dr. Gerhard Sattler, Dr. Ada Trindade de Almeida, Dr. Rungsima Wanitphakdeedecha, Dr. Philip Werschler, Dr. Tatjana Pavicic
- Biostimulating Fillers and Induction of Inflammatory Pathways: a Preclinical Investigation of Macrophage Response to Calcium Hydroxylapatite (CaHA) and Poly-L Lactic Acid (PLLA). Presenting author: Dr. Bartosch Nowag; Co-authors: Dr. Daniela Schäfer, Dr. Thomas Hengl, Dr. Niamh Corduff, Dr. Kate Goldie
- Awareness of Aesthetic and Therapeutic Crossover Usage of Botulinum Toxin Type A. Presenting author: Dr. Carina Daughtry, Co-authors: Susie Albion MSN, RN, Samantha Gokhale PhD.
- Glycerol, a Well-Tolerable Humectant in Dermal Fillers. Presenting author: Dr. Thomas Hengl; Co-authors: Dr. C. Hartmann, Dr. K. Marquardt, Dr. C. Wollenburg, Dr. Daniela Schäfer
- Tissue Integration of Hyaluronic Acid Containing Dermal Fillers: An Unbiased, Automated, and Comprehensive Approach to Systematically Compare Dermal Fillers. Presenting author: Dr. Thomas Hengl; Co-authors: Dr. K. Marquardt, Dr. C. Hartmann, Dr. J. Franken, Dr. C. Wollenburg
- Technical Evaluation and In Vitro Studies of Different CaHA-Containing Dermal Fillers: Considering the Impact of Particle Characteristics on Biostimulation. Presenting author: Dr. Cleiton Kunzler; Co-authors: Dr. C. Hartmann, Dr. B. Nowag, Dr. R. El-Banna, Dr. S. Backfisch, Dr. Daniela Schäfer, Dr. R. Stragies, Dr. Thomas Hengl, Dr. N. Hagedorn
- Comparative Clinical and Histomorphological Evaluation of the Injectable Cohesive Polydensified Matrix Hyaluronic Acid and Calcium Hydroxylapatite Combination. Presenting author: Dr. Yana Yutskovskaya; Co-authors: Dr. Е. А. Kogan, Dr. A. Yu. Koroleva
About Merz Aesthetics
Merz Aesthetics is a medical aesthetics business with a long history of empowering health care professionals, patients and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves — however they define it. Clinically proven, its product portfolio includes injectables, devices and skin care treatments designed to meet each patient’s needs with high standards of safety and efficacy. Being family owned for more than 110 years, Merz Aesthetics is known for building unique connections with customers who feel like family. Merz Aesthetics’ global headquarters is in Raleigh, N.C., USA, with a commercial presence in 52 countries worldwide. It is also a part of Merz Group, which was founded in 1908 and is based in Frankfurt, Germany. Learn more at merzaesthetics.com
Copyright © 2023 Merz Aesthetics GmbH. All rights reserved. MERZ, MERZ AESTHETICS and the MERZ logo are registered trademarks of Merz Pharma GmbH & Co. KGaA.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230126005003/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Perma-Pipe International Holdings, Inc. Announces Fourth Quarter and Fiscal 2024 Financial Results1.5.2025 22:24:00 CEST | Press release
The Company generated net sales of $45.0 million for the quarter and $158.4 million for the yearIncome before income taxes of $5.3 million for the quarter and $18.5 million for the yearBacklog of $138.1 million at January 31, 2025, compared to $68.5 million at January 31, 2024 Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) announced today financial results for the fourth quarter and 2024 fiscal year ended January 31, 2025. “Sales for the fourth quarter and full year 2024 show moderate growth and were $45.0 million and $158.4 million, resulting in increases of $4.8 million and $7.7 million, compared to the prior year. Income before taxes was $5.3 million and $18.5 million in the fourth quarter and for the full year 2024, which increased by $2.1 million and $8.6 million, compared to the prior year. This significant increase was a result of our focus on higher margin products and services that contributed to improved margin performance. Net income after taxes and minority interest
IFF Declares Dividend for Second Quarter 20251.5.2025 22:15:00 CEST | Press release
IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 11, 2025 to shareholders of record as of June 20, 2025. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience.Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2025 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved. View source version on businesswire.com: https://www.businesswire.com/news/home/20250501776988/en/
Rimini Street Announces Fiscal First Quarter 2025 Financial and Operating Results1.5.2025 22:01:00 CEST | Press release
First Quarter Financial Highlights Include: Gross margin of 61.0% compared to 59.8% in the prior year Net Income of $3.4 million compared to $1.3 million in the prior year Billings of $79.4 million, up 7.2% year over year Adjusted EBITDA of $15.3 million compared to $10.7 million in the prior year Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced results for the fiscal first quarter ended March 31, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501664008/en/ Select First Quarter 2025 Financial Results Revenue was $104.2 million for the 2025 first quarter, a decrease of 2.4% compared to $106.7 million for the same period last year. U.S. revenue was $50.1 million for the 2025 first quarter, a decrease of 6.9% compared to $53.8 million for the same per
Textron Aviation Calls on Cessna, Beechcraft and Hawker Owners to Transport Athletes to the 2026 Special Olympics USA Games1.5.2025 17:31:00 CEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the coordination of the ninth Special Olympics Airlift, a monumental event aimed at transporting hundreds of athletes and coaches across country to the 2026 Special Olympics USA Games in Minnesota’s Twin Cities. The company is calling on Cessna, Beechcraft and Hawker aircraft owners and operators to come together on Friday, June 19, 2026, and Saturday, June 27, 2026, to enable champions from all corners of the nation to travel to and from the host city, regardless of financial or logistical challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430812758/en/ Textron Aviation Inc. announced the coordination of the ninth Special Olympics Airlift, a monumental event aimed at transporting hundreds of athletes and coaches across country to the 2026 Special Olympics USA Games in Minnesota’s Twin Cities. (Photo credit: Textron Aviation) The Special Oly
Giovanni Brienza Appointed President of Frontline International1.5.2025 17:16:00 CEST | Press release
Longtime leader to guide day-to-day operations Frontline International, celebrating 25 years of innovation in commercial kitchen solutions, has appointed Giovanni Brienza as its new president. Founder John Palazzo will continue as CEO, focusing on strategic direction and long-term growth initiatives. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501026483/en/ Giovanni Brienza, Frontline International President Frontline is a USA-based manufacturer of systems used globally by foodservice operations for safer, more sustainable fat, oil, and grease (FOG) management. The company’s automated solutions increase kitchen safety. Brienza, who joined Frontline in 2004, brings 21 years of operational expertise and engineering insight to his new role. He has been a key architect behind many of Frontline’s most impactful innovations, from equipment and software systems to strategically expanding the company’s footprint into key inter
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom